• MJHLS Brand Logo

© 2020 MJH Life Sciences™ and Rheumatology Network. All rights reserved.

Psoriatic Arthrits Quiz: Treatment Options

Jul 16, 2019

In psoriatic arthritis, exhibiting different comorbidities may require different treatment regimens. In this installment of our monthly psoriatic arthritis quiz, we present a few different scenarios. How good are you at coming up with an effective treatment plan? Test your knowledge with this quiz.

In psoriatic arthritis, exhibiting different comorbidities may require different treatment regimens. In this installment of our monthly psoriatic arthritis quiz, we present a few different scenarios. How good are you at coming up with an effective treatment plan? Test your knowledge with this quiz.

(©Qingwa,AdobeStock)

Source:  Blum U, Buitrago-Tellez C, Mundinger A, et al. “M. Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI.” The Journal of Rheumatology. 1996 Dec;23(12):2107-15. (©Qingwa,AdobeStock)

Source:  Blum U, Buitrago-Tellez C, Mundinger A, et al. “M. Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI.” The Journal of Rheumatology. 1996 Dec;23(12):2107-15. (©Qingwa,AdobeStock)

Source:  Blum U, Buitrago-Tellez C, Mundinger A, et al. “M. Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI.” The Journal of Rheumatology. 1996 Dec;23(12):2107-15. (©Qingwa,AdobeStock)

Source:  Singh, Jasvinder A., et al. "2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis." Arthritis & Rheumatology 71.1 (2019): 5-32. (©Qingwa,AdobeStock)

Source:  Singh, Jasvinder A., et al. "2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis." Arthritis & Rheumatology 71.1 (2019): 5-32. (©Qingwa,AdobeStock)

Source:  Singh, Jasvinder A., et al. "2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis." Arthritis & Rheumatology 71.1 (2019): 5-32. (©Qingwa,AdobeStock)

Source:  Menon K, Van Voorhees AS, Bebo Jr BF, Gladman DD, Hsu S, Kalb RE, Lebwohl MG, Strober BE, Foundation NP. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 2010 Feb 1;62(2):291-9. (©Qingwa,AdobeStock)

Source:  Menon K, Van Voorhees AS, Bebo Jr BF, Gladman DD, Hsu S, Kalb RE, Lebwohl MG, Strober BE, Foundation NP. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 2010 Feb 1;62(2):291-9. (©Qingwa,AdobeStock)

Source:  Menon K, Van Voorhees AS, Bebo Jr BF, Gladman DD, Hsu S, Kalb RE, Lebwohl MG, Strober BE, Foundation NP. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. Journal of the American Academy of Dermatology. 2010 Feb 1;62(2):291-9. (©Qingwa,AdobeStock)

Source:  Haroon M, Chaudhry AB, Fitzgerald O. “Higher prevalence of metabolic syndrome in patients with psoriatic arthritis: a comparison with a control group of noninflammatory rheumatologic conditions.” The Journal of Rheumatology. 2016 Feb 1;43(2):463-4.  (©Qingwa,AdobeStock)

Source:  Haroon M, Chaudhry AB, Fitzgerald O. “Higher prevalence of metabolic syndrome in patients with psoriatic arthritis: a comparison with a control group of noninflammatory rheumatologic conditions.” The Journal of Rheumatology. 2016 Feb 1;43(2):463-4. (©Qingwa,AdobeStock)

Source:  Haroon M, Chaudhry AB, Fitzgerald O. “Higher prevalence of metabolic syndrome in patients with psoriatic arthritis: a comparison with a control group of noninflammatory rheumatologic conditions.” The Journal of Rheumatology. 2016 Feb 1;43(2):463-4. (©Qingwa,AdobeStock)

Source:  Rohekar S, Tom BD, Hassa A, Schentag CT, Farewell VT, Gladman DD. “Prevalence of malignancy in psoriatic arthritis.” Arthritis and Rheumatism. January 2008. DOIi:10.1002/art.23185. (©Qingwa,AdobeStock)

Source:  Rohekar S, Tom BD, Hassa A, Schentag CT, Farewell VT, Gladman DD. “Prevalence of malignancy in psoriatic arthritis.” Arthritis and Rheumatism. January 2008. DOIi:10.1002/art.23185. (©Qingwa,AdobeStock)

Source:  Rohekar S, Tom BD, Hassa A, Schentag CT, Farewell VT, Gladman DD. “Prevalence of malignancy in psoriatic arthritis.” Arthritis and Rheumatism. January 2008. DOIi:10.1002/art.23185. (©Qingwa,AdobeStock)

PreviousNext